Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M25.0Revenue $M8.3Net Margin (%)-209.8Altman Z-Score-4.3
Enterprise Value $M12.6EPS $-1.1Operating Margin %-190.1Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-209.6Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %-43.7Quick Ratio6.9Cash flow > EarningsN
Price/Sales2.35-y EBITDA Growth Rate %-52.4Current Ratio6.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-104.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-121.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.5ROIC % (ttm)-195.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ROSG is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

    More From Other Websites
    Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q4, 2015 By the Numbers Apr 13 2016
    Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: 2015 By the Numbers Apr 13 2016
    ROSETTA GENOMICS LTD. Financials Mar 29 2016
    ROSG: Revenue Growth Accelerated in 4Q15 Mar 28 2016
    Rosetta Genomics Reports 2015 Full Year Financial Results Mar 23 2016
    Rosetta Genomics Reports 2015 Full Year Financial Results Mar 23 2016
    Full Year 2015 Rosetta Genomics Ltd Earnings Release - Time Not Supplied Mar 23 2016
    Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on... Mar 17 2016
    Rosetta Genomics Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development Feb 29 2016
    Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of Three New Product Offerings Feb 25 2016
    Rosetta Genomics Receives Approval from New York State for First-of-its-kind Thyroid Cancer... Feb 18 2016
    Rosetta Genomics to Present at Source Capital's 2016 Disruptive Growth & Healthcare Conference Feb 08 2016
    Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of... Feb 01 2016
    Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of... Feb 01 2016
    Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for... Jan 25 2016
    Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for... Jan 25 2016
    Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules for the Treatment of... Jan 11 2016
    CORRECTING and REPLACING Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules... Jan 11 2016
    Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the... Jan 06 2016
    Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the... Jan 06 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)